Kamala Harris Raked in Cash from Big Tech During Democrat Primary
During the 2020 Democrat presidential primary, Sen. Kamala Harris (D-CA) was bestowed with the most billionaire donations out of the nearly 30 candidates who ran for the nomination.
During the 2020 Democrat presidential primary, Sen. Kamala Harris (D-CA) was bestowed with the most billionaire donations out of the nearly 30 candidates who ran for the nomination.
Big pharmaceutical corporations are raking in billions from American taxpayers through the United States government deals that are funding research for a vaccine to the Chinese coronavirus.
Drugs can be manufactured in America more quickly, efficiently, and with better quality control than in China, said Rosemary Gibson, senior adviser at the Hastings Center and author of China Rx: Exposing the Risks of America’s Dependence on China for Medicine.
Restoring American generic drug manufacturing would create “hundreds of thousands of good-paying STEM jobs,” explained Rosemary Gibson, author of “China Rx: Exposing the Risks of America’s Dependence on China for Medicine,” on Tuesday’s edition of SiriusXM’s Breitbart News Tonight with host Rebecca Mansour.
America’s “mainstream media” often act as apologists for China’s Communist Party, noted Tom Cotton while discussing the coronavirus outbreak.
Bringing pharmaceutical production back to the United States would create more than 800,000 American jobs, economists say.
Sure this Coronavirus pandemic is a misery but I’m much more optimistic than most at the moment. Here’s one of the reasons: there’s an effective treatment already and it’s available and cheap, according to studies.
The coronavirus outbreak exposes the need to protect domestic medicine and medical supplies manufacturing as a “strategic national asset,” explains “China Rx” author Rosemary Gibson.
Pharmaceutical companies expect to soon begin paying “human guinea pigs” £3,500 (upwards of $4,500) to be infected with the coronavirus in a race to discover a vaccine for the disease, The Times reports.
A tentative $6-8 billion “emergency funding” bill to address the coronavirus outbreak does nothing to lessen America’s dependence on China for supplies of basic and essential medicines, said Rosemary Gibson, author of China Rx: Exposing the Risks of America’s Dependence on China for Medicine.
Pharmaceutical companies have been punching bags for Democratic presidential candidates throughout the 2020 primary — but now that they are needed to produce a vaccine for coronavirus, attacking them doesn’t look so good.
A poll shows that the majority of Americans do not blame drug companies for the deaths of thousands of people from opioid overdoses.
Sen. Kamala Harris (D-CA) slammed the nation’s largest pharmaceutical companies as “high-level dope dealers” on Tuesday.
During the CNN and New York Times Democrat debate on Tuesday night, Sen. Elizabeth Warren (D-MA) suggested that politicians cannot pretend to take on Big Tech and big pharmaceutical corporations after taking their donations — something Sen. Kamala Harris (D-CA) has continued to do throughout her run for president.
Sen. Bernie Sanders (I-VT) slammed Joe Biden (D) Sunday following reports of the former vice president praising drug companies at a fundraiser over the weekend.
An ABC News report published Wednesday reveals that Sen. Bernie Sanders’ (I-VT) campaign has received donations from “big pharma,” despite his campaign’s “No Health Insurance and Pharma Money Pledge.” His campaign, however, has promised to return the donations.
Democrat presidential contender Amy Klobuchar pledged during Wednesday’s debate to take on pharmaceutical companies if elected in 2020.
The White House will put measures in place as soon as this summer to require further transparency from drug advertisers.
The Rochester Drug Co-operative and its former CEO Laurence Doud III were charged on Tuesday with conspiring to defraud the Drug Enforcement Administration (DEA) — and the rest of the country.
Dr. Phil said Medicare and Medicaid transformed medicine into a “high-volume business” in which quality is sacrificed in pursuit of quantity.
As the Trump administration pushes for drug price transparency, the pharmaceutical industry is already trying to subvert the coming changes.
Attorneys for a county in East Texas announced Wednesday they filed a lawsuit in federal court against more than a dozen pharmaceutical companies for their alleged roles in the opioid painkiller epidemic gripping the state and the nation.
A professor and the director of InHealth Associates have claimed that Google’s depression diagnosis tool “is driving people quicker down the path to big pharma.”
President Donald J. Trump, in his exclusive Oval Office interview with Breitbart News on Monday afternoon, hammered the Democratic National Committee (DNC) on its rigged race for the newly elected chairman against supporters of Sen. Bernie Sanders (I-VT).
As we think about mobilizing to win the war against disease, disability, and premature death, we might start by thinking about how we’ve won our wars in the past.
The fate of Obamacare dominates the news—again. Eight years ago, anti-Obamacare Republicans and Tea Partiers were on the offensive. Today, it’s pro-Obamacare Democrats, perhaps joined by “astroturf” activists, on the offense. Congressional Republicans have had plenty of time to think through their preferred alternative to Obamacare in the seven years since it was signed into law. So what is the hang-up? Part of the problem is the GOP has never really come to grips with the basic question: Do Americans have a right to health insurance?
During last year’s presidential campaign, candidate Donald Trump said that if elected, he would save the federal government billions by forcing the pharmaceutical companies to negotiate—that is, lower—their prices.
President Donald Trump made big news on January 31, when he met in the White House with top pharmaceutical company executives. Or at least he deserved to make big news, because the issues he raised in the West Wing’s Roosevelt Room will prove to be central to the health, and wealth, of every American.
AFL-CIO president Richard Trumka praised GOP President Donald Trump’s decision to withdraw from the Trans Pacific Partnership once and for all on Monday with an executive order officially killing the Pacific Rim trade deal.
The Speaker of the House of Representatives, failed one-time GOP vice presidential candidate Paul Ryan, is picking a fight with incoming President Donald J. Trump and Vice President Mike Pence over the Trump administration’s vow to tackle corruption in Big Pharma.
Drug stocks plummeted as President-Elect Donald Trump announced that he wants “new bidding procedures” for Big Pharma that would force drug companies to compete for government contracts.
NEW ORLEANS, Louisiana – Prescription pain-killers are more prevalent than people in Louisiana; according to a new report that shows widespread opioid issues across eight states.